BioRestorative Therapies (BRTX) director Steven Collier Brown submits Form 3
Rhea-AI Filing Summary
BioRestorative Therapies, Inc. has a new insider report from Steven Collier Brown, who is identified as a company director. This Form 3 serves as his initial statement as a reporting person and, in the data provided, lists no buy, sell, or derivative transactions.
Positive
- None.
Negative
- None.
Key Figures
Reporting persons: 1
Reported insider transactions: 0
2 metrics
Reporting persons
1
Number of individuals listed as reporting persons in the Form 3
Reported insider transactions
0
Total buy, sell, and derivative transactions reported in this Form 3
Key Terms
Form 3, reportingPersons, derivativeSummary
3 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3) for BioRestorative Therapies, Inc."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reportingPersons regulatory
""reportingPersons": [{"name": "Brown Steven Collier"}]"
derivativeSummary financial
""derivativeSummary": [] appears in the structured insider data"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the new Form 3 for BRTX disclose?
The Form 3 for BioRestorative Therapies, Inc. identifies Steven Collier Brown as a company director and establishes him as a reporting person. The data show no reported purchases, sales, or derivative transactions in this initial ownership report.
Who is the reporting person in BioRestorative Therapies (BRTX) Form 3?
The reporting person is Steven Collier Brown, listed as a director of BioRestorative Therapies, Inc. This filing begins his status as a reporting insider for the company’s equity securities under SEC rules.
Does the BRTX Form 3 show any stock purchases or sales by Steven Collier Brown?
No. The insider data for this Form 3 report zero buy transactions and zero sell transactions. It also lists no derivative exercises, gifts, or restructurings in connection with this initial ownership statement.
Are any derivative securities reported for Steven Collier Brown in BRTX?
No derivative positions are shown. The derivativeSummary section is empty and the transaction summary reports 0 derivative transactions, indicating no options or similar instruments are listed in this Form 3 data.
What insider role does Steven Collier Brown hold at BioRestorative Therapies (BRTX)?
Steven Collier Brown is flagged as a director of BioRestorative Therapies, Inc. in the insider data. He is not identified as an officer or 10% owner in this Form 3 report.